These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 708628)

  • 21. The evaluation of the role of androgens in hirsutism and the use of a new anti-androgen "cyproterone acetate" for therapy.
    Ismail AA; Davidson DW; Souka AR; Barnes EW; Irvine WJ; Kilimnik H; Vanderbeeken Y
    J Clin Endocrinol Metab; 1974 Jul; 39(1):81-95. PubMed ID: 4835125
    [No Abstract]   [Full Text] [Related]  

  • 22. [Cyproterone acetate. 15 cases of hirsutism treated for 1 year].
    Houdent C; Kuhn JM; Balacheff O; Leclerc P; Legrand A; Wolf LM
    Ann Endocrinol (Paris); 1983; 44(6):397-401. PubMed ID: 6234850
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cyproterone acetate for severe hirsutism: results of a double-blind dose-ranging study.
    Barth JH; Cherry CA; Wojnarowska F; Dawber RP
    Clin Endocrinol (Oxf); 1991 Jul; 35(1):5-10. PubMed ID: 1832346
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of cyproterone acetate orally on hair density and diameter and endocrine factors in women with idiopathic hirsutism.
    Peereboom-Wynia JD; Boekhorst JC
    Dermatologica; 1980; 160(1):7-16. PubMed ID: 7188692
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cyproterone acetate for hirsutism.
    Van der Spuy ZM; le Roux PA
    Cochrane Database Syst Rev; 2003; 2003(4):CD001125. PubMed ID: 14583927
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Relapse of hirsutism following long-term successful treatment with oestrogen-progestogen combination.
    Kokaly W; McKenna TJ
    Clin Endocrinol (Oxf); 2000 Mar; 52(3):379-82. PubMed ID: 10718837
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Management of virilization with an antiandrogen-containing contraceptive].
    Apró G; Sas M
    Orv Hetil; 1981 Jul; 122(30):1821-4. PubMed ID: 6458007
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Treatment of hirsutism and acne in women with two combinations of cyproterone acetate and ethinylestradiol.
    Cremoncini C; Vignati E; Libroia A
    Acta Eur Fertil; 1976 Dec; 7(4):299-314. PubMed ID: 140576
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effects of cyproterone acetate and ethinyl oestradiol on carbohydrate metabolism.
    Seed M; Godsland IF; Wynn V; Jacobs HS
    Clin Endocrinol (Oxf); 1984 Dec; 21(6):689-99. PubMed ID: 6239714
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Treatment of hirsutism and acne. Sequential inverse therapy with anti-androgen-estrogen].
    Lebeau M; Vokaer R
    J Gynecol Obstet Biol Reprod (Paris); 1972; 1(7):715-21. PubMed ID: 4267704
    [No Abstract]   [Full Text] [Related]  

  • 31. [Inhibition of ovulation with 35 micrograms of ethinyl estradiol and 2 mg of cyproterone acetate (Diane 35)].
    Spona J; Huber J; Schmidt JB
    Geburtshilfe Frauenheilkd; 1986 Jul; 46(7):435-8. PubMed ID: 3093307
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Therapeutic alternatives for the hirsute woman.
    Bassaw B; Maharaj R; Ali A; Roopnarinesingh S
    West Indian Med J; 1992 Mar; 41(1):12-4. PubMed ID: 1533080
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Antiandrogen treatment of acne and hirsutism in women (proceedings)].
    Kaiser E; Loch EG; Hartmann P
    Arch Gynakol; 1977 Jul; 224(1-4):428-9. PubMed ID: 146466
    [No Abstract]   [Full Text] [Related]  

  • 34. [Experience in treating androgen-dependent diseases (androgenetic alopecia, acne agminata, hirsutism) with the preparation Diane].
    Rubina VV; Korchevaia TA; Kravchenko LIa
    Vestn Dermatol Venerol; 1986; (7):21-5. PubMed ID: 2945335
    [No Abstract]   [Full Text] [Related]  

  • 35. A role for a non-androgenic anovulant in the management of hirsutism.
    McKenna TJ; Cunningham SK
    Ir J Med Sci; 1991 Jul; 160(7):194-6. PubMed ID: 1757211
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of the clinical efficacy of flutamide and spironolactone plus ethinyloestradiol/cyproterone acetate in the treatment of hirsutism: a randomised controlled study.
    Karakurt F; Sahin I; Güler S; Demirbas B; Culha C; Serter R; Aral Y; Bavbek N
    Adv Ther; 2008 Apr; 25(4):321-8. PubMed ID: 18389188
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cyproterone acetate and the treatment of hirsutism.
    Fraser IS; Shearman RP; Allen JK; McCarron G
    Aust N Z J Obstet Gynaecol; 1983 May; 23(2):93-8. PubMed ID: 6226279
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Hormonal treatment of hirsutism].
    Floersheim Y; Keller PJ
    Schweiz Med Wochenschr; 1976 Apr; 106(17):573-4. PubMed ID: 982010
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ultrasound study of ovarian and uterine morphology in women with polycystic ovary syndrome before, during and after treatment with cyproterone acetate and ethinyloestradiol.
    Venturoli S; Paradisi R; Saviotti E; Porcu E; Fabbri R; Orsini LF; Bovicelli L; Flamigni C
    Arch Gynecol; 1985; 237(1):1-10. PubMed ID: 2932064
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Use of cyproterone acetate (CPA) in the treatment of acne, hirsutism and virilism.
    Hammerstein J; Meckies J; Leo-Rossberg I; Moltz L; Zielske F
    J Steroid Biochem; 1975 Jun; 6(6):827-36. PubMed ID: 126335
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.